Spiriva Respimat 2
Sponsors
Hospices Civils De Lyon, Fundacio Privada Mon Clinic Barcelona
Conditions
AsthmaChronic Obstructive Pulmonary Disease
Phase 4
Symptoms control and adhErenCe assessment during treatment with mepolizUmab new pREfilled devices. SECURE
CompletedCTIS2022-501029-19-00
Start: 2022-12-13End: 2025-03-27Target: 130Updated: 2024-01-15
THE ANTES B+ STUDY: AN OPEN-LABEL, PRAGMATIC, RANDOMIZED, CONTROLLED TRIAL OF TRIPLE THERAPY VERSUS LABA-LAMA COMBINATION TO IMPROVE CLINICAL CONTROL IN HIGH-RISK GOLD B PATIENTS (B+)
CompletedCTIS2023-507304-32-00
Start: 2024-02-09End: 2025-01-23Target: 1028Updated: 2024-04-04